The Dividend Yield as of November 2024 (TTM) for Processa Pharmaceuticals, Inc. (PCSA) is 0%

According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Processa Pharmaceuticals, Inc. (PCSA) Historical Dividend Yield (quarterly & annually)

How has PCSA Dividend Yield performed in the past?

The mean historical Dividend Yield of Processa Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PCSA's Dividend Yield was at its highest in in the September 2016 quarter at 0.30%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Processa Pharmaceuticals, Inc. (PCSA) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Processa Pharmaceuticals, Inc. (PCSA) Average Dividend Yield

How has PCSA Dividend Yield performed in the past?

The current Dividend Yield of Processa Pharmaceuticals, Inc. (PCSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Processa Pharmaceuticals, Inc. (PCSA) Dividend Yield vs. Peers

How is PCSA’s Dividend Yield compared to its peers?

Processa Pharmaceuticals, Inc.’s Dividend Yield is less than Alpha Cognition Inc. (0%), less than Eupraxia Pharmaceuticals Inc. (0%), less than Acurx Pharmaceuticals, Inc. (0%), less than Fennec Pharmaceuticals Inc. (0%), less than Comera Life Sciences Holdings, Inc. (0%), less than SAB Biotherapeutics, Inc. (0%), less than Fresh Tracks Therapeutics, Inc. (0%), less than Third Harmonic Bio, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Inhibrx Biosciences, Inc. (5.49%), less than Merrimack Pharmaceuticals, Inc. (99.70%), less than Celcuity Inc. (0%), less than Enliven Therapeutics, Inc. (0%), less than AN2 Therapeutics, Inc. (0%), less than Miromatrix Medical Inc. (0%), less than Inhibikase Therapeutics, Inc. (0%), less than PMV Pharmaceuticals, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Akari Therapeutics, Plc (0%), less than Armata Pharmaceuticals, Inc. (0%), less than Scopus BioPharma Inc. (0%),

Build a custom stock screener for Processa Pharmaceuticals, Inc. (PCSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Processa Pharmaceuticals, Inc. (PCSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.